Nuvation Bio Inc - Ordinary Shares - Class A Forecast, price target & analysts
Nuvation Bio Inc - Ordinary Shares - Class A Target price 2026 - Analyst rating & recommendation
Nuvation Bio Inc - Ordinary Shares - Class A Classifications & Recommendation
Nuvation Bio Inc - Ordinary Shares - Class A Price Target
| Target Price | $12.75 |
| Price | $5.74 |
| Potential |
122.13%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Nuvation Bio Inc - Ordinary Shares - Class A 2027 .
The average Nuvation Bio Inc - Ordinary Shares - Class A target price is $12.75.
This is
122.13%
register free of charge
$22.05
284.15%
register free of charge
$7.07
23.17%
register free of charge
|
|
| A rating was issued by 18 analysts: 16 Analysts recommend Nuvation Bio Inc - Ordinary Shares - Class A to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Nuvation Bio Inc - Ordinary Shares - Class A stock has an average upside potential 2027 of
122.13%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 62.90 | 203.07 |
| 699.24% | 222.85% | |
| EBITDA Margin | -335.98% | -64.74% |
| 84.15% | 80.73% | |
| Net Margin | -325.33% | -67.55% |
| 95.49% | 79.24% |
14 Analysts have issued a sales forecast Nuvation Bio Inc - Ordinary Shares - Class A 2026 . The average Nuvation Bio Inc - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Nuvation Bio Inc - Ordinary Shares - Class A EBITDA forecast 2026. The average Nuvation Bio Inc - Ordinary Shares - Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Nuvation Bio Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2026. The average Nuvation Bio Inc - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.60 | -0.39 |
| 71.56% | 35.00% | |
| P/E | negative | |
| EV/Sales | 8.73 |
14 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast for earnings per share. The average Nuvation Bio Inc - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Nuvation Bio Inc - Ordinary Shares - Class A...
Current Nuvation Bio Inc - Ordinary Shares - Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citizens |
Locked
➜
Locked
|
Locked | Sep 16 2026 |
| Wedbush |
Locked
➜
Locked
|
Locked | Sep 16 2026 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Aug 21 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 18 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 27 2026 |
| Wedbush |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Citizens:
Locked
➜
Locked
|
Sep 16 2026 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Sep 16 2026 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Aug 21 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 18 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 27 2026 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Jul 23 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
